Finance

Lists
Why is CYRX down 3.43%?
Dive Deeper
CYRX:NASDAQ
CryoPort Inc
$16.76
-3.43%
(-0.60) 1D
Oct 8, 12:09:45 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CYRX...
Open
$17.20
High
$17.42
Low
$16.74
Mkt. cap
848.63M
Avg. vol.
648.86K
Volume
260.31K
52-wk high
$18.36
52-wk low
$7.61
EPS
-$0.91
Beta
1.96
Shares outstanding
50.65M
No. of employees
688
Open
$17.20
High
$17.42
Low
$16.74
Mkt. cap
848.63M
Avg. vol.
648.86K
Volume
260.31K
52-wk high
$18.36
52-wk low
$7.61
EPS
-$0.91
Beta
1.96
Shares outstanding
50.65M
No. of employees
688
News stories
From web sources and news partners
About CryoPort Inc
CEO-
Employees688
Founded1990
HeadquartersBrentwood, Tennessee, United States
SectorHealth care
Websitecryoportinc.com
Analyst ratings
Based on 5 analysts giving stock ratings to CYRX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for CYRX in the last 3 months.
Highest
Current $16.76
$25.00 (+49.21%)
Average
$20.80 (+24.14%)
Lowest
$19.00 (+13.40%)
Analyst
Recommendation
Action
Price target
Projected
Date
Subbu Nambi
Guggenheim
Buy
Maintained
$19.00
+13.4%
10/01/2026
David Larsen
BTIG
Buy
Maintained
$25.00
+49.2%
09/18/2026
Matt Hewitt
Craig-Hallum
Buy
Reiterated
$20.00
+19.4%
08/07/2026
Richard Baldry
Roth MKM
Buy
Reiterated
$21.00
+25.3%
08/07/2026
David Saxon
Needham
Buy
Reiterated
$19.00
+13.4%
08/07/2026
Matthew Stanton, CFA
Jefferies
Hold
Maintained
$13.00
-22.4%
06/08/2026
Paul Knight
KeyBanc
Buy
Maintained
$17.00
+1.5%
05/20/2026
Greg Palm
Craig-Hallum
Buy
Maintained
-
-
04/17/2026
George Sutton
Craig-Hallum
Buy
Initiated
-
-
04/07/2026
Unknown Analyst
Jefferies
Hold
Reiterated
$9.50
-43.3%
04/01/2026
Unknown Analyst
Guggenheim
Buy
Maintained
$11.00
-34.3%
03/03/2026
Unknown Analyst
Stephens
Buy
Maintained
$13.00
-22.4%
03/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
44.23M
45.45M
47.80M
48.97M
Cost of goods sold
22.91M
23.74M
25.88M
26.15M
Cost of revenue
22.91M
23.74M
25.88M
26.15M
Research and development expenses
4.52M
4.47M
3.91M
4.85M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.54M
17.63M
27.60M
27.98M
Operating expense
31.06M
22.10M
31.51M
32.84M
Total operating expenses
53.97M
45.84M
57.40M
58.98M
Operating income
-9.73M
-386.00K
-9.60M
-10.01M
Other non operating income
144.00K
-926.00K
191.00K
114.00K
EBT including unusual items
-6.53M
-7.40M
-9.32M
-7.75M
EBT excluding unusual items
-6.99M
2.33M
-7.20M
-7.94M
Income tax expense
165.00K
1.13M
108.00K
505.00K
Effective tax rate
-2.53%
-15.23%
-1.16%
-6.52%
Other operating expenses
-
-
-
-
Net income
-6.94M
-11.64M
-10.54M
-8.26M
Net profit margin
-15.70%
-25.62%
-22.06%
-16.86%
Earnings per share
-0.13
-0.17
-0.19
-0.20
Interest and investment income
3.40M
3.36M
3.09M
3.13M
Interest expense
-526.00K
-634.00K
-432.00K
-518.00K
Net interest expenses
2.88M
2.72M
2.66M
2.61M
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.88M
8.53M
-3.20M
-3.42M
Gain or loss from assets sale
-
3.96M
30.00K
34.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps